Homoserine lactone hydrobromide → 2-(4-{4-[(benzyl{2-methyl-3-[(methylsulfonyl)amino]phenyl}amino)methyl]phenoxy}phenoxy)-N-(2-oxotetrahydrofuran-3-yl)acetamide

HRID 1370955Notes

Reaction equation

HRID 1370955 reaction equation
[CH2:1]([N:8]([CH2:21][C:22]1[CH:39]=[CH:38][C:25]([O:26][C:27]2[CH:37]=[CH:36][C:30]([O:31][CH2:32][C:33](O)=[O:34])=[CH:29][CH:28]=2)=[CH:24][CH:23]=1)[C:9]1[CH:14]=[CH:13][CH:12]=[C:11]([NH:15][S:16]([CH3:19])(=[O:18])=[O:17])[C:10]=1[CH3:20])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.Br.[NH2:41][CH:42]1[CH2:47][CH2:46][O:45][C:43]1=[O:44]>>[CH2:1]([N:8]([CH2:21][C:22]1[CH:23]=[CH:24][C:25]([O:26][C:27]2[CH:28]=[CH:29][C:30]([O:31][CH2:32][C:33]([NH:41][CH:42]3[CH2:47][CH2:46][O:45][C:43]3=[O:44])=[O:34])=[CH:36][CH:37]=2)=[CH:38][CH:39]=1)[C:9]1[CH:14]=[CH:13][CH:12]=[C:11]([NH:15][S:16]([CH3:19])(=[O:17])=[O:18])[C:10]=1[CH3:20])[C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1

Participants

3

Reactant 2

HCID 73508Homoserine lactone hydrobromideHCID 11410199(4-(4-((Benzyl(2-methyl-3-((methylsulfonyl)amino)phenyl)amino)methyl)phenoxy)phenoxy)acetic acid

Product 1

HCID 102113872-(4-{4-[(benzyl{2-methyl-3-[(methylsulfonyl)amino]phenyl}amino)methyl]phenoxy}phenoxy)-N-(2-oxotetrahydrofuran-3-yl)acetamide

Procedure

The product from Example 95C and alpha-amino-gamma-butyrolactone hydrobromide were processed as described in Example 251A to provide the titled compound. 1H NMR (500 MHz, DMSO-d6) δ8.94 (s, 1 H), 8.62 (d, 1 H), 7.23 (m, 7 H), 7.00 (m, 7 H), 6.84 (d, 2 H), 4.69 (dd, 1 H), 4.52 (d, 2 H), 4.36 (m, 1 H), 4.23 (dd, 1 H), 4.05 (s, 2 H), 4.00 (s, 2 H), 2.91 (s, 3 H), 2.39 (m, 4 H), 2.27 (m, 1 H); MS (ESI+) m/z 630 (M+H)+.

Sources & evidence

ORD record
ord-656f99e998c246dca93e7522a099d4f9
Source dataset
uspto-grants-2003_06
Patent number
US06583180B2

Reaction notes

Loading…